| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681228 | Brain and Development | 2018 | 9 Pages |
Abstract
High dose phenobarbitone appears to be an effective therapeutic modality in pediatric refractory status epilepticus. The current study provides a protocol for its use which can be validated in future studies with larger sample size.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Sheffali Gulati, Vishal Sondhi, Biswaroop Chakrabarty, Prashant Jauhari, Rakesh Lodha, Jhuma Sankar,